Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease
Helena Iznardo(Hospital de Sant Pau), L. Puig(Universitat Autònoma de Barcelona)
Cited by 72
Related Papers
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
|Journal of Allergy and Clinical Immunology|2020|160
Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain
|Journal of Dermatological Treatment|2018|74
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study
|American Journal of Clinical Dermatology|2024|58